MALIGNANT NEOPLASM OLIGOPROGRESSION

This adverse event was reported 199 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM OLIGOPROGRESSION:

# Drug Count
0 CARBOPLATIN 47
1 PEMETREXED DISODIUM 28
2 PEMETREXED 25
3 NIVOLUMAB 19
4 PACLITAXEL 19
5 BEVACIZUMAB 16
6 IPILIMUMAB 14
7 FULVESTRANT 12
8 RIBOCICLIB 9
9 LORLATINIB 7
See all common drugs associated with MALIGNANT NEOPLASM OLIGOPROGRESSION

MALIGNANT NEOPLASM OLIGOPROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEMIPLIMAB-RWLC 4 0.0019
1 TEBENTAFUSP 1 0.0017
2 BEVACIZUMAB-BVZR 1 0.0014
3 LORLATINIB 7 0.0009
4 PEMETREXED DISODIUM 28 0.0007
5 FLURBIPROFEN 1 0.0007
6 PRALSETINIB 1 0.0005
7 AFATINIB 3 0.0005
8 ALECTINIB HYDROCHLORIDE 3 0.0004
9 ENFORTUMAB VEDOTIN 3 0.0004
See all drugs enriched for association with MALIGNANT NEOPLASM OLIGOPROGRESSION